Get the Stockscreener App
3.03
47.80%
0.98
Pre-market:
2.68
-0.35
-11.55%
Profusa Inc stock is traded at $3.03, with a volume of 78.83M.
It is up +47.80% in the last 24 hours and down -33.84% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$2.05
Open:
$3.51
24h Volume:
78.83M
Relative Volume:
28.58
Market Cap:
$1.84M
Revenue:
$75,000
Net Income/Loss:
$-42.41M
P/E Ratio:
-0.0169
EPS:
-179.8206
Net Cash Flow:
$-18.47M
1W Performance:
+68.33%
1M Performance:
-33.84%
6M Performance:
+42.39%
1Y Performance:
-96.75%
1-Day Range:
$2.39
$4.18
1-Week Range:
$1.81
$4.18
52-Week Range:
$0.3204
$120.00
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
3.03 | 1.84M | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
Why Is Micro Cap Stock Profusa Soaring Today?Profusa (NASDAQ:PFSA) - Benzinga
Discover the most active stocks in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Which stocks are moving on Thursday? - ChartMill
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark - Yahoo Finance
Premarket Movers: GCTK and PFSA Among Gainers, ARTL and BENF Among Losers - ChartMill
Profusa jumps as CE-mark progress update appears to spark speculative buying - Quiver Quantitative
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000 - Benzinga
PFSA Stock Whipsaws As Traders Track Extreme Volatility - StocksToTrade
PFSA Stock Whipsaws As Traders Target Volatile Moves - timothysykes.com
Profusa, Inc. Announces Significant Progress Towards Lumee Oxygen Platform - marketscreener.com
PFSA Stock Jumps On Volatile Surge As Traders Circle - StocksToTrade
PFSA Stock Volatility Draws Traders After Sharp Rebound - timothysykes.com
Wondering what's happening in today's pre-market session? - ChartMill
Profusa receives ISO 13485 certification for quality system - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
PFSA Stock Sees Wild Swings As Traders Target Volatility - timothysykes.com
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October - The Manila Times
Profusa receives ISO 13485 certification for quality system By Investing.com - Investing.com India
EU review remains for Profusa's tissue-oxygen monitor after a positive quality-system decision. - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Profusa Shareholders Endorse Reverse Stock Split Authorization Ranging from 1-for-2 to 1-for-12 - Kalkine Media
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - stocktwits.com
Form 8K Profusa Inc For: 16 September By Investing.com - Investing.com India
Profusa Regains Nasdaq Compliance, Enters One-Year Monitoring - The Globe and Mail
Profusa Raises $350,000 Via Senior Secured Convertible Note to Ascent, 7% Rate, $4.28 Conversion - TradingView
Form 8K Profusa Inc For: 15 September By Investing.com - Investing.com Nigeria
Profusa clears Nasdaq compliance issues - tradingview.com
Profusa Regains Nasdaq Compliance But Faces One-Year Mandatory Panel Monitor - Minichart
Profusa regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria
Profusa regains compliance with Nasdaq listing requirements - Investing.com
Profusa cleared Nasdaq bid-price and equity rules, placed on one-year mandatory monitor - TradingView
Profusa, Inc. Receives Nasdaq Compliance Determination Letter Confirming Bid Price and Equity Rule Compliance - Quiver Quantitative
ProfusaRemains Subject to One-Year Mandato - moomoo.com
Profusa, Inc. Common Stock (NASDAQ: PFSA) Share Price, PFSA Stock News, PFSA Share Price & Updates - Kalkine
Profusa CEO Jack E. Stover Reports Zero Shares Held Following Two $0 Transactions on August 21, 2026 - kalkinemedia.com
Profusa (PFSA) CFO shifts stake from sponsor to direct - Stock Titan
Profusa (PFSA) CEO restructures 334K-share holding - Stock Titan
PROFUSA INC (PFSA) Stock Chart - ChartMill
Profusa Issues $329,670 Senior Secured Convertible Note to Ascent; $300,000 Proceeds, 7% Interest - TradingView
Profusa Confirms Continued Compliance With Nasdaq Listing Standards - The Globe and Mail
Profusa Announces September 18 Virtual Special Meeting to Approve Reverse Stock Split Plan - Kalkine Media
Profusa Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Profusa Regains Nasdaq Compliance for Publicly Held Shares Requirement - Minichart
Profusa Receives Nasdaq Notice on Publicly Held Shares Requirement, Compliance Confirmed and Review Closed - Quiver Quantitative
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement - Yahoo Finance
HRT Financial LP Reduces Stake in Profusa Inc (PFSA) Amid Deteriorating Fundamentals - GuruFocus
Profusa amends financing deal, resets debt conversion price at $1.07 per share - Bitget
Profusa Raises $714K Via Convertible Note, Moves to Exchange $6.14M Debt for Preferred With Ascent - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):